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Abstract.  We have produced two lines of transgenic 
mice in which the expression of temperature-sensitive 
SV-40 large T  antigen is targeted to bone marrow 
megakaryocytes via the platelet factor 4  (PF4) tissue- 
specific promoter.  The progeny of these transgenic 
mice were observed for about 3 mo, and no malignan- 
cies were detected over this period of time.  The 
offspring of these transgenic mice, 6- to  12-wk of age, 
served as a  source of bone marrow cells, which upon 
in vitro cultivation at the permissive temperature 
yielded immortalized cell lines (MegT). At the per- 
missive temperature,  MegT cells exhibit the character- 
istics of early 2N and 4N megakaryocytes which in- 
elude the presence of specific gene products such as 
PF4, glycoprotein Hb, acetylcholinesterase, and CD45 
as well as the absence of molecular markers of other 
cell lineages such as the rnacrophage marker Mac-l, 
the T helper cell marker CIM, the mast cell marker 
IgE, the T  cell marker CD2 or the erythroid cell 
marker ot-globin.  The inactivation of the oncogene by 
a  shift of temperature from 34 ° to 39.5°C produces 
a  reduction in the frequency of the 2N cells, in con- 
junction with the appearance of 8N and  16N cells, 
consisting of 27 and 3%  of total cells, respectively. 
Thus,  we have generated hematopoietic cell lines that 
are trapped in the early stages of megakaryocyte com- 
mitment,  but able to undergo part of the normal pro- 
gram of terminal differentiation. 
p 
LURIPOTENT bone marrow stem cells give rise to 2N 
megakaryoblasts  which  are  subsequently converted 
to mature polyploid megakaryocytes as a  result of 
DNA replication  in the absence of mitosis and the develop- 
ment of or-granules  which contain  specific  gene products 
(Hawiger et al., 1987). The mature megakaryocytes then frag- 
ment into small  anucleate platelets  which circulate  within 
the blood. Past studies of megakaryocyte biochemistry and 
differentiation have been hampered because these cells con- 
stitute only 0.05-0.1% of the nucleated cells of bone marrow. 
The currently available cell lines,  all derived from patients 
with leukemia,  exhibit multilineage  properties and/or low 
ploidy states (Martin and Papayannopoulou,  1982; Tabilio et 
al.,  1983; Tabilio et al.,  1984; Ogura et al.,  1985; Sledge 
et al.,  1986; Greenberg et al.,  1988). Therefore,  the use of 
a molecular biological approach to generate megakaryocytic 
cell lines which maintain  lineage fidelity and become poly- 
ploid would constitute  a significant  advance in this field of 
research. 
We have used tissue-specific  expression  of a conditional 
oncogene in transgenic mice to produce immortalized mega- 
karyocytic cell lines.  In prior studies,  transient  expression 
experiments  as well as transgenic  mice were used to define 
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the tissue-specific  elements  of the platelet factor 4  (PF4) ~ 
gene and the promoter region which allows selective expres- 
sion in megakaryocytes and platelets (Ravid et al., 1991a,b). 
We now describe the generation  of transgenic mice express- 
ing the temperature-sensitive  SV-40 large T antigen  driven 
by  the  above  tissue-specific  regulatory  domain  (Meg-T 
mice). This conditional oncogene has previously been linked 
to retroviral  vectors to immortalize in vitro precursors of 
neural  cells (Frederiksen et al.,  1988) and myogenic  cells 
(Iujuidin et al., 1990). The offspring of the Meg-T transgenic 
mice serve as a source of primary bone marrow cells which 
yield immortalized  2N or 4N megakaryocytes when cultured 
at the permissive temperature and subsequently transform 
to higher ploidy states when cultured at the nonpermissive 
temperature.  Thus,  our investigations  demonstrate that he- 
matopoietic cells can be immortalized at a specific stage of 
commitment with a lineage  specific-promoter linked  to a 
conditional  oncogene. 
Materials and Methods 
Experimental Procedures 
Plasmid Construction  and Generation of ITansgenic Mice. The plasmid 
1.  Abbreviations used in  this paper:  GM-CSF,  granulocyte-macrophoge 
colony stimulating factor; IL, interleukin; IMDM, Iscove's modification of 
Dulbecco's  medium; PF4, platelet factor 4; vWF, von-W'fllebrand Factor. 
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contains the rat 1.1-kb PF4 promoter linked to the HGH gene. This con- 
struct has a unique EcoRI site at the 3' end of the HGH gene and a unique 
Banll site 20-bp downstream  of the transcriptional start. A unique KpNI 
site was  introduced at the 5' end of the PF4 promoter in pPF4GH,  via 
linkers, to produce pPF4GHr~. This later plasmid was digested with BanlI 
and EcoRI to remove the HGH gene and a BglH/ECORI SVtsA58 fragment 
(Frederiksen et al., 1988) was introduced, via BanH/BglII tinkers, to gener- 
ate pPF4SVtsA58.  The orientation of insertion of the SVtsA58 gene was 
confirmed by DNA sequencing. The PF4 promoter/SVtsA58  gene of 3.6 kb 
was obtained by cutting pPF4SVtsA58 with KpNI and EcoRI and purifying 
the appropriate fragment by agarose gel electrophoresis.  This fragment was 
used to produce transgenic mice as described previously  (Ravid et al., 
199la). Foster mice females were of ICR strain (Harland, Frederick, MD) 
and the microinjected eggs were of FVB strain (Taconic Farms, German- 
town, NY). Mice were screened for transgene integration by Southern blot 
analysis of tail DNA (Hogan et al., 1986) and transgene expression was de- 
tected by Northern blot analyses  (Ravid et al.,  1991a). 
Cultured Cells. Mouse bone marrow cells were isolated and cultured as 
described previously  (Ravid et al.,  1991/7). The cells were grown in 5% 
CO2 at 34°C in a liquid culture under conditions that were shown before 
to support maturation and ploidy of primary megakaryocytes (Kuter et al., 
1989).  To  this end,  the  cells were  grown in the presence of Iscove's 
modification of Dulbecco's medium (IMDM) supplemented with penicillin 
(2,000 U/mi), streptomycin (200/tg/ml), L-glutamine (0.592 mg/ml), horse 
serum (20%), and the hemopoietic growth factors erythropoietin (1 U/ml), 
Interleukin (IL)-3 (5 ng/ml), IL-6 (5 ng/ml), and granulocyte-macrophage 
colony-stimulating  factor (GM-CSF) (5 ng/ml). The immortal cells derived 
were cloned by seeding 200-500 cells/10 ml IMDM supplemented as above 
in a  100-mm-diam  culture dish. Individual colonies were isolated with a 
glass cloning ring, removed from the plate by trypsinization and grown in 
a 35 mm dish. To induce cell differentiation,  0.5-1  ×  105 cells were seeded 
into a 25 cm  2 culture flask in the presence of 5 ml of the above medium 
and incubated in 5% CO2 at 39.5°C  for 4 to 5 d. Cells were counted by 
hemocytometer and cell death was followed by staining with "lYypan  blue. 
Immunofluorescent Staining. Cell lines were grown on glass cover 
slides for 3 to 4 d, bone marrow cells were spun onto a polylysine-treated 
slide in a Cytospin 2 (Shannon, Pittsburgh, PA) and both cell types were 
subjected  to immunofluorescence  staining as described in (Ravid et al., 
1993) except that fixation was carried out with 100% methanol for 2 rain 
at room temperature. 
Flow Cytometric Analysis and Fluorescence Activated Cell Sorting 
(FACS). For analysis of DNA content per cell, adhering cell lines were tryp- 
sinized  and then washed  with culture media whereas bone marrow ceils 
were harvested in CATCH (Ravid et al.,  1991b) and both cell types were 
stained with Hoechst dye (Ravid et al.,  1991a). Flow cytometric analysis 
and FACS were carried out on a FACStarplns flow cytometer (a registered 
trademark of Becton Dickinson, San Jose, CA) (Kuter et al.,  1989; Ravid 
et al.,  1991a) and DNA histograms were analyzed by a cell cycle analysis 
program (Modfit Verity Software House,  Inc., Topsham, ME). The ploidy 
analysis of mouse bone marrow cells, using a rat platelet antibody, was done 
as described (Kuter et al., 1989). A coefficient of variation of the 2N peak 
was maintained at 2.2 to 3.0% by alignment of the optical  system. 
Northern Blot Analyses and Polymerase Chain Reaction. Total RNA 
was prepared from cells grown at 34  ° or 39.5°C and subjected to Northern 
blot analyses as described in (Ravid et al., 1991a). The different probes used 
were cDNAs of GPHb (gift of Dr. M. Foncz), vWF (gift of Dr. D. Lynch), 
wglobin (gift of Dr. L. Gehrke), PF4 (Doi et al., 1987), and the gene coding 
for T antigen (Frederiksen et al., 1988). Low levels of messenger RNA were 
detected by the PCR as described in (Ravid et al., 1991b). The PCR primers 
used to detect CD2 (Diamond et al.,  1988) were:  5'GGTCGGTGCAGG- 
AGG3' (sense) and 5'CGA~CAGGTGTCY (antisense) which extend 
267 bp. 
Materials. The materials used and their sources were as follows: tissue 
culture media and horse serum (GIBCO-BRL,  Gaithersburg, MD); hema- 
topoietic growth factors (R&D Systems, Minneapolis, MN); Hoechst dye, 
polylysine,  and diisopropylfluorophosphate  (Sigma Immunochemicals, St. 
Louis, MO) PCR reagents (Perkin-Elmer Cetus, Norwalk,  CT); PKH2-GL 
and PKI-I26-GL dyes (Zynaxis Cell Science, Inc., Malvern, PA); M-MLV 
reverse  transcriptase  (GIBCO-BRL);  mAbs  against  CD45R  (GIBCO- 
BRL), Mac-1 (Bochringer Mannheim, Indianapolis, IN), and L3T4 anti- 
body against CD4 (Becton Dickinson Immunocytometry System, San Jose, 
CA);  antibody against IgE  (Nordic  Immunological  Lab,  Tilburg,  The 
Netherlands); antibody to large T antigen (Oncogene Science,  Manhasset, 
NY); [,~-32P]ATP and [c¢-35S]ATP (New England Nuclear Research Prod- 
ucts, Boston, MA); and oligonucleotides  were synthesized  with fl-cyano- 
ethylphosphamidates  by the Biopolymers Laboratory at M.I.T. 
Results 
Generation of Transgenic Mice Containing the PF4 
Promoter Linked to the Temperature-sensitive Mutant 
of SV-40 Large T Antigen 
The  construct used  to  generate  transgenic  mice contains 
1,104 bp of the 5' upstream region of the rat PF4 gene linked 
to the tsA58  mutant  SV-40 large T antigen (PF4SVtsA58) 
(Fig.  1 a). The oncogene used encodes a mutant gene prod- 
uct which is rapidly  degraded by raising the temperature 
from 34 °  to  39°C  (Tegtemeyer  1975a,b).  Given that  the 
mouse  body  temperature  is  about  38°C  (Kaplan  et  al., 
1983), large T protein should be at very low concentrations 
or absent under in vivo conditions. The above segment of the 
PF4 promoter was selected because our previous transgenic 
studies demonstrated that the critical tissue-specific regula- 
tory  domain  is  located  within this  region  (Ravid  et  al., 
1991a).  PF4SVtsA58  was microinjected into pronuclei of 
fertilized mouse eggs  and the  injected  embryos  were im- 
planted into pseudopregnant outbred females. The offspring 
were screened for transgene  integration by  Southern blot 
analyses of tail DNA digested with PstI, using the SVtsA58 
gene as a probe (Fig.  1 b).  Five founder mice were iden- 
tiffed, of 33  mice produced,  exhibiting  1 to  10 copies of 
PF4SVtsA57 as determined by comparison with diluted lin- 
earized control DNA. While not very low, the percentage of 
transgenic mice obtained is lower than our usual results with 
other constructs. We do not rule out the possibility that this 
is related to an effect of SV-40 large T antigen in early stage 
embryos.  The transgene was integrated  into a single chro- 
mosomal site in a head-to-tail fashion, as judged by the 2.5- 
and  1.1-kb DNA  fragments  obtained  after  digestion  with 
PstI. The offspring of the founders were tested for T antigen 
expression in bone marrow cells and other tissues by North- 
ern blot analyses  (Fig.  1 c).  The results indicated that the 
bone marrow cells of the offspring of founders 10 and 18 pos- 
sessed a low level of oncogene mRNA.  However, the liver, 
skeletal muscle, heart,  brain, kidney,  adrenal,  and lung of 
offspring  from the above founders were negative for trans- 
gene expression.  This observation confirms the tissue-spe- 
cific nature of the PF4 promoter used. 
Analyses of the Hematopoietic System 
of Transgenic Mice 
We have  carefully monitored alterations  in the transgenic 
mice colony over a period of about three months. No abnor- 
malities  were  recorded  except  for  the  sudden  death  of 
founder 10 at the age of 11 wk. Unfortunately,  it was not pos- 
sible to carry  out an autopsy on this animal.  The platelets 
and  megakaryocytes  from the blood and bone marrow of 
transgenic mice (ages 6-12 wk) were examined by immuno- 
histochemical methods to determine whether large T antigen 
was present.  The results  showed that these cell types pos- 
sessed no detectable level of oncogene protein under in vivo 
conditions  (not  shown).  Platelets  were  also  counted  in 
whole-blood samples collected from age-matched transgenic 
and nontransgenic mice. The mean platelet counts, as deter- 
mined by hemocytometer (Kuter et al.,  1989), were 680  + 
102  ×  103/~1 (n  =  3) in transgenic mice and 730  +  90  × 
103//~1 (n  =  3) in non-transgenic mice. The extent of bone 
marrow  megakaryocyte  ploidy  was  also  evaluated  in two 
transgenic  (offspring  of  founder  10)  and  non-transgenic 
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tively (the results are from a representative experimen0. The 
relatively high percentage of mouse 2N megakaryocytes de- 
tected as compared to that reported in rats and mice (Corash 
et al.,  1987; Kuter et al.,  1989) may have been due to low 
level nonspecific binding of antibody to nonmegakaryocytic 
mouse bone marrow cells which comprise 99.9%  of cells 
analyzed. 
Figure L  (A) The PF4SVtsA58 construct used for production of 
transgenic mice. The construct contains 1.1 kb of the 5' upstream 
region of the rat PF-,4 promoter linked to 2.57 kb of STtsA58 gene. 
K, Kpn I cohesive ends; E, EcoRI cohesive ends; and P, Pst I site. 
(B) Southern blot analyses of 10/~g of DNA isolated from different 
founders, digested with PstI, and fractionated by 1.2 % agarose gel 
eleetrophoresis. DNA concentrations were determined by absor- 
bancy at 260 nm before loading on the agarose gel. The figure in 
parenthesis indicates the number of copies of DNA integrated into 
a single chromosomal site as determined with a linearized control 
DNA (data not shown). Lambda DNA HindlB markers are indi- 
cated by arrows. (C) Northern blot analysis of 20 t~g of total RNA 
prepared  from bone  marrow cells of the  offspring of different 
founders (18, 17, 14, 10, and 27) as well as the lung (L), spleen (S), 
heart (H), brain (B), skeletal muscle (SK), adrenal (A), and liver 
(/2) of the offspring  of founder 18. The blots were probed with the 
T antigen gene fragment and the bands shown correspond to the T 
antigen message. Equal loading of  RNA was confirmed  by ethidium 
bromide staining  of  the ribosomal  bands 28S (5 kb) and 18S (2.5 kb). 
The experimental details are provided in Materials and Methods. 
mice. The above parameter was determined by identifying 
megakaryoeytes  by cell surface labeling with antibody to rat 
platelets and then estimating the amount of DNA per cell by 
flow cytometry as described previously (Kuter et al., 1989). 
A non-transgenic mouse exhibited a megakaryocyte ploidy 
distribution of 39.2,  17.7, 5.6, and 10.4%  for 2N, 4N,  8N, 
and 16N or higher, respectively, whereas a transgenic mouse 
possessed a megakaryocyte ploidy distribution of 40.8, 16.8, 
Establishment of Bone Marrow Cell Lines 
Bone marrow cells were derived from the offspring of all 
transgenic mice and cultured at the permissive temperature 
of 340C  in a  liquid culture as described in Materials and 
Methods. Centrifugation was used to replace 50 % of the me- 
dia every 4  d  and resuspended cells were returned to the 
original dish. After 4 wk of culture, the nonadhering and ad- 
hering cells originating from the offspring ofail founders, ex- 
cept 10 and 18, died. Within days, colonies of adhering cells 
derived from the offspring of founders 10 and 18 filled the 
dishes.  These cells were cloned by the ring cloning tech- 
nique, expanded to obtain stocks and subsequently frozen. 
Clone 37  derived from offspring 37  of founder 10 (desig- 
nated as MegT37) and clones 1 and 8 from founder 18 (desig- 
nated as MegTl and MegTS) were further characterized. At 
34°C, cells were spindle shaped and adherent and showed no 
change in morphology up to ,,030 passages. At 39.50C, cells 
attached with an efficiency of 50-80 %, and then gradually 
detached and rounded up over 4 to 5 d in culture after which 
cell  death  was  observed.  About  30%  of the  ceils  were 
identified as dead at day six in culture at 39.5°C. It should 
be pointed out that immunofluorescence  staining with an an- 
tibody to large T antigen revealed that the oncogene product 
was degraded only after about 2 d in culture at 39.5°C, after 
which the cell number did not increase (not shown). The 
cells MegT37 and MegT1 grew at 34°C with a doubling time 
of 22 h  while MegT8  grew with a doubling time of 30 h. 
However, upon prolonged culturing MegT8 displayed a dou- 
bling time of 24 h. When the immortal cells were cultured 
at 37°C the cells remained adhering to the dish and con- 
tinued cycling, albeit, with a doubling time of  42 h. This later 
observation correlates with our finding that at 37°C the cul- 
tured cells still possess the oncogene product (not shown). 
Lineage Properties of the Cell Lines 
The identity of  the cell lines was established by documenting 
the  presence  of lineage  specific  markers  with  immuno- 
histochemical  and  Northern  blot  analyses.  MegT37  ex- 
hibited a strong positive staining with an antibody to rat PF4 
(Fig. 2, a and b). As controls, all mouse bone marrow cells 
with the exception of megakaryocytes were negative (Fig. 2, 
c and d). MegT37 cells alsO showed weak positive staining 
with an antibody to CD45 antigen, but were otherwise nega- 
tive  with  antibodies  to  the  macrophage-specific  antigen 
Mac-l,  T  helper cell  specific antigen CD4  and mast cell 
specific antigen IgE (not shown) (Spangrude et al.,  1988). 
MegT37 also possessed the megakaryocytic marker acetyl- 
choline esterase (Jackson, 1973)  (Fig. 2, e and f). Similar 
results were obtained with the other cell lines (not shown). 
Northern blot analyses were used to detect expression of 
Ravid et al. Immortalization  of Megakaryocytes by Large T Antigen  1547 Figure 2. The presence of lineage-specific  markers in MegT37.  Immunottuorescence photomicrographs of MegT37 cells cultured at 34°C 
(4) or of normal mouse bone marrow cells (C) stained with an antibody to rat PF,4 (Doi et al., 1987).  Phase-contrast photomicrographs 
of the same MegT37 cells cultured at 34°C (B) or the same normal mouse bone marrow cells (D). Staining for acetylcholine esterase 
for six-seven hours in the absence of (E) or presence of (F) an enzyme inhibitor (0.5  mM diisopropylfluoropbosphate) as described 
in (Iackson, 1973). Original magnification: ×400 (A-D), or  ×100 (E and F). The experimental details are provided in Materials and 
Methods. 
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gens are not available and to compare the levels of  the T anti- 
gen message in the different cell lines. A significant amount 
of the large T  antigen message was noticed in all cell lines 
with the order MegT1  >  MegT37 >  MegT8 (Fig.  3).  The 
mRNA for von-Willebrand Factor (vWF) was not detected in 
the cells (not shown) nor was the erythroid marker ot-globin 
(Nishioka  and  Leder,  1979)  while  the  messages  for the 
megakaryoeytic markers GPllb and the PF4 were detectable 
either at 34* or at 39.5°C (Fig. 3). As also seen in Fig. 3, 
the level of the PF4 message in all the cell lines cultured at 
the permissive conditions was similar to the level detected 
when the ceils were cultured at 39.5°C while the level of the 
GPHb message increased by about two fold upon shifting the 
cells to 39.50C.  The existence of the PF4 and GPIIb mes- 
sages in the cell lines was also confirmed by amplifying re- 
verse transcribed mRNA by the polymerase chain reaction 
(data not shown). This method was also used to exclude the 
presence of mRNA for the T cell surface marker CD2 (Dia- 
mond et al., 1988) to which rodent cDNA was not available 
to us. The results shown in Figs. 2 and 3 and in the text are 
summarized in Table I which lists all the lineage markers 
tested and indicates their presence or absence in our MegT 
cell lines. 
In Vitro Ploidy of the Megakaryocytic  Cell Lines 
To ascertain whether inactivation of large T  antigen would 
allow MegT37 to become polyploid, the cell line was ana- 
lyzed for DNA content per cell by flow cytometry as outlined 
in Materials and Methods. The localization of the 2N peak 
was confirmed by using mouse bone marrow cells as control 
(Fig. 4  a). When grown at 34°C, the majority of MegT37 
(95 %) exhibited 2N or 4N nuclei, with very few cells pos- 
sessing 8N nuclei (Fig. 4 b). When grown at 39.5°C, the fre- 
quency of MegT37 with 2N nuclei decreased to about 25 %, 
and those with 8N nuclei increased to about 30 %, with some 
cells possessing 16N nuclei (Fig. 4 c). Phase-contrast pho- 
tomicrographs of the cells grown at 340C (Fig. 4  d) or at 
39.50C (Fig. 4 e) were taken before flow cytometry analyses. 
At 34°C,  cells were spindle shaped and adherent while at 
39.5°C a large fraction of the cells detached from the plate. 
All of these non-adhering cells appeared oval or round and 
about 70% of them had a diameter larger than that of a 2N 
cell (>10-15/~m), large nuclei and multiple nucleoli. To ex- 
clude the possibility that cell fusion might have generated 
MegT37 with nuclei greater than 4N, two pools of cells were 
separately labeled with red fluorescence dye PKH2-GL or 
green fluorescence dye PKH26-GL before cultivation. The 
labeled cells were mixed in equal numbers, grown at 34  ° or 
39.5°C for 4 to 5 d, stained with Hoechst dye, and analyzed 
by flow cytometry. We then determined the single and double 
Figure 3. The determination of lineage-specific markers in different 
cell lines. 30 t~g of total RNA from mouse bone marrow cells (lane 
1), MegT1 (lanes 2 and 3), MegT8 (lanes 4 and 5) and MegT37 
(lanes 6 and 7) cultured at 34°C (lanes 2, 4, and 6) or 39.5°C (lanes 
3, 5, and 7), was electrophoresed (1% agarose) per lane; equal load- 
ing was confirmed by ethidinm bromide staining of the ribosomal 
bands 28S (5 kb) and 18S (2.5 kb) (A). The gel from A was sub- 
jected to Northern blot analysis and probed with a-globin cDNA, 
PF4 cDNA, and GPI~ cDNA. RNA was also prepared from cells 
grown at 34°C, subjected to Northern blot analysis and probed with 
the T antigen gene (~g) (B). The experimental details are provided 
in Materials and Methods. The blots were either subjected to auto- 
radiography  or  scanned by Betascope  (Betagen Co.,  Waltham, 
MA). 
Table L Lineage Properties of MegT Cells 
Hematopoietic cells  Lineage markers  MegT cells 
Megakaryocytes  PF4  + 
Acethycholine esterase  + 
GPIlb  + 
vWF 
Myelomonocytes  Macl 
T  cells  CD4  - 
CD2 
Mast cells  IgE 
Erythrocytes  a-Globin  - 
Leukocytes  CD45  +* 
The table indicates the presence (+) or absence (-) of markers of different 
hematopuietic lineages in  MegT cells,  as concluded from the experiments 
presented in Figs.  2  and 3  and in the text. The distribution of the various 
markers was identical  at 34  ° and at 39.50C. 
* A weak positive staining with an antibody to CD45 was observed in MegT 
cells, however, a reaction of similar intensity was also observed in primary 
bone marrow megakaryocytes of low ploidy class (Kuter, D. J., unpublished 
observation). 
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Figure 4. The flow cytometric and electron microscopic examina- 
tion of MegT37. Flow cytometric analysis of normal mouse bone 
marrow cells (A), or MegT37 cells cultured for 4 d at 34"C (B), 
or at 39.5°C (C), respectively.  The abscissa shows the DNA content 
on a logarithmic  scale,  determined  based on fluorescence due to 
Hoechst staining, and the ordinate reflects the number of cells at 
each DNA value (linear scale). Two times repetition of this experi- 
ment yielded identical results. The results shown are from a repre- 
sentative assay. The experimental details are provided in Materials 
and Methods. Phase-contrast photomicrographs of  samples of  cells 
grown at 34°C (D), or at 39.5"C (E). Original magnification x200. 
Cells grown at 39.5°C were also subjected to electron microscopic 
analysis (F) as described before (Ravid et al., 1993). Original mag- 
nification:  x5538.  The arrows point to the different lobes in the 
large multilobulated nucleus which occupies a large portion of the 
cytoplasma,  thus resulting with a high nuclear-cytoplasmic  ratio. 
This morphology is characteristic  of polyploid megakaryocytes. 
labeled cells in the total population and within each ploidy 
class. Within the total cell population, 7--8  % of  the cells were 
double labeled at 34°C and 10-11%  at 39.5°C.  The genera- 
tion of double labeled cells is most likely to occur because 
of cell fusion but a small contribution from dye transfer can 
not be excluded. The percentage of cells undergoing fusion 
in a cell population should be equivalent to three times the 
percentage of double labeled cells (red, green; green, green; 
red, red). Therefore, cell fusion could generate a maximum 
of "~ 30 % of the polyploid megakaryocytes. Similar results 
were obtained when each ploidy class was separately ana- 
lyzed (data not shown).  Based on these analyses, we con- 
clude that at least 70 % of the polyploid MegT37 cells must 
have arisen from 2N megakaryocytes by DNA replication 
without  cell  division.  Similar ploidy analyses carded  out 
with MegT1 and MegT8 cells revealed a minimal number of 
~>8N cells (not shown). 
The electron microscopic analyses of MegT37 grown at 
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cleus and a high nuclear-cytoplasmic ratio which is charac- 
teristic  of  polyploid  megakaryocytes.  However,  typical 
t~-granules were absent while lysosomes were readily appar- 
ent (Fig. 4 f).  The large nucleus and lysosomes were not 
present in cells grown at 34°C (not shown). 
Several attempts were made to induce MegT37 to convert 
to cells with 16N and 32N nuclei at frequencies observed in 
normal murine bone marrow (Corash et al., 1987; Kuter et 
al.,  1989).  These manipulations included addition of he- 
mopoietic growth factors (see Methods) and phorbol ester 
or  dimethylsulfoxide, known  to  induce  differentiation in 
erythroleukemia cell lines (Greenberg et al., 1988),  as well 
as co-culture of MegT37 (prelabeled with fluorescent dye) 
with normal mouse bone marrow. No augmentation in the 
extent of ploidy of MegT37 was observed. It should also be 
noted that differentiation of the cell line in agar cultures at 
39.5°C under colony forming unit conditions (Chatelain et 
al., 1983) was unsuccessful because of the poor stability of 
agar (1-2 %). 
Discussion 
Several different oncogenes encode nuclear proteins which 
are able to immortalize somatic cells in vitro. In some cases, 
oncogene expression induces the formation of tumor cells 
which synthesize many of the major differentiation  products 
of normal cells from which they are derived (Amsterdam et 
al.  1988;  Garcia et al.,  1986;  Moura Neto et al.,  1986; 
Muller and Wagner,  1984).  In other situations, oncogene- 
mediated cell immortalization inhibits expression of the ter- 
minaUy differentiated state (Beug et al.,  1987; Cherington 
et al., 1986; Dmitrovsky et al., 1986; Falcone et al., 1985). 
The availability of conditional oncogenes makes it poten- 
tially possible to establish cell lines which cycle at the per- 
missive conditions, and differentiate under nonpermissive 
conditions in the presence of appropriate growth factors. In- 
deed, retroviral vectors driving the expression of conditional 
oncogenes such as SV-40 large T or myc have been used in 
vitro to produce cell lines having the potential to differentiate 
(Frederiksen et al., 1988; Iujvidin et al., 1990; Eilers et al., 
1989).  Viral and cellular non-conditional oncogenes have 
been also used in vivo to produce transgenic mice (Leder et 
al., 1986; Andres et al., 1987; Bender and Pfeifer, 1987; Ma- 
hon et al., 1987; Efrat et al., 1988; Harris et al., 1988; Rey- 
nolds et al.,  1988).  In each case, tumors were noted in tis- 
sues that are targets for high levels of oncogene expression 
which frequently caused the death of the transgenic mice. 
In the present study, we attempted to generate hematopoi- 
etic cell lines that could provide models for lineage program- 
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oncogenes into pluripotent mouse hematopoietic cells has 
previously been reported (Williams et al., 1984).  However, 
we used the PF4 promoter linked to a temperature-sensitive 
SV-40 large T antigen to target oncogene expression in trans- 
genic mice to a specific hematopoietic cell lineage. The use 
of this conditional oncogene allowed the large T antigen  to 
be maintained in an inactive state in transgenic mice, which 
have  a body  temperature  higher than  the permissive one. 
This later feature permitted the mice to exhibit normal hema- 
topoietic cell function for at least three months and prevented 
the emergence of hematopoietic tumors during this period of 
time. However, it is possible that the death of founder 10 was 
due to the leaky nature of the conditional oncogene in con- 
junction with slight variations  in body temperature.  Given 
that  the  focus of our work was to generate  immortalized 
megakaryocytes, we did not study potential changes in these 
mice with aging. The bone marrow cells obtained from the 
young transgenic mice were cultured at 34°C which yielded 
immortalized cell lines expressing megakaryocytic charac- 
teristics, e.g., PF4, GPI]b, and acetylcholinesterase. In con- 
trast to bone marrow megakaryocytes, the immortalized cell 
lines do not contain vWE contain relatively low levels of PF4 
mRNA, and consist mainly of cells with 2N and 4N nuclei. 
It may be that vWF is expressed in mature megakaryocytes 
of high ploidy class and thus will not be detected in our cell 
lines. It is possible that the low extent of PF4 expression is 
due to competition for trans-acting  factors, the later resulting 
from the high copy number of the transgene.  Alternatively, 
the low level of PF4 message may be typical of low ploidy 
bone marrow megakaryocytes.  However, the PF4 protein was 
definitely detectable by antibody staining. 
The  successful  production  of  immortalized  cell  lines 
which exhibit lineage fidelity depends on the ability to in- 
duce cell differentiation in vitro.  Our cell lines respond to 
a rise in temperature  with inactivation  of the oncogene and 
changes in cell behavior and morphology. The MegT37 cells 
initiate and progress along a differentiation pathway includ- 
ing arrest of cellular proliferation, enlargement of cell size, 
frequent detachment from the plate, increase in the nuclei/ 
cytosol  ratio,  and  appearance  of cells  with  8N  and  16N 
nuclei.  Although a cocktail of hemopoietic growth factors 
was used, we were unable to stimulate MegT cells to become 
polyploid to the same extent as normal mouse bone marrow 
megakaryocytes  nor to form a-granules.  In normal mega- 
karyocyte  differentiation,  CD34 positive cells initially ex- 
hibit platelet specific membrane glycoproteins and only later 
develop o~-granules and full ploidy (Debili, N.,  C. Issaad, 
J. M. Masse, J. Guichard, A. Katz, J. Berton Gorious, and 
W. Vainchenker.  1992. Blood.  80:126a).  It is possible that 
the liquid culture system used at the high temperature  lacks 
cellular interactions and/or an unknown growth factor that 
are critical for formation of high ploidy ceils and for a-gran- 
ule formation in cells that have been subjected to immortal- 
ization. Thus, MegT cells might undergo normal maturation 
if transplanted  into  the  bone marrow of irradiated  mice. 
Based upon the above data,  we believe that these cell lines 
constitute a new tool for investigating  the biology of early 
megakaryocytes as well as of polyploid cells. We also believe 
that  our  molecular  biological  approach  used  to  generate 
megakaryocytic cell lines should assist in future studies on 
oncogene-mediated  immortalization  of  megakaryocytic 
cells. 
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